|
Original Articles in Peer-Reviewed Journals |
|||
|
Title
|
Author(s)
|
Journal
|
Pub.
Year |
| Lyn- and PLC-{beta}3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease. |
Xiao W, Ando T, Wang HY, Kawakami Y, Kawakami T. | Blood. | 2010 |
| JNK1 controls mast cell degranulation and IL-1{beta}production in inflammatory arthritis. |
Guma M, Kashiwakura J, Crain B, Kawkami Y, Beutler B, Firestein GS, Kawakami T, Karin M, Corr M. | P Natl Acad Sci USA. | 2010 |
| Tyrosine phosphorylation of SHIP promotes its proteasomal degradation. |
Ruschmann J, Ho V, Antignano F, Kuroda E, Lam V, Ibaraki M, Snyder K, Kim C, Flavell RA, Kawakami T, Sly L, Turhan AG, Krystal G. |
Exp Hematol. | 2010 |
| FcepsilonRI beta-chain ITAM amplifies P13K-signaling to ensure synergistic degranulation response via FcepsilonRI and adenosine receptors. |
Nunomura S, Gon Y, Yoshimaru T, Kashiwakura J, Kawakami T, Ra C. |
Eur J Immunol. | 2010 |
| A minor catalytic activity of Src family kinases is sufficient for maximal activation of mast cells via the highaffinity IgE receptor. |
Poderycki M, Tomimori Y, Ando T, Xiao W, Maeda-Yamamoto M, Sauer K, Kawakami Y, Kawakami T. |
J Immunol. | 2010 |
| Mast cells in atopic dermatitis. |
Kawakami T, Ando T, Kimura M, Wilson BS, Kawakami Y. | Curr Opin Immunol. | 2009 |
| A crucial door to the mast cell mystery knocked in. |
Kawakami T. | J Immunol. | 2009 |
| Small, mobile FcepsilonRI receptor aggregates are signaling competent. |
Andrews NL, Pfeiffer JR, Martinez AM, Haaland DM, Davis RW, Kawakami T, Oliver JM, Wilson BS, Lidke DS. | Immunity. | 2009 |
| Polyclonal IgE induces mast cell survival and cytokine production. |
Kashiwakura J, Kawakami Y, Yuki K, Zajonc DM, Hasegawa S, Tomimori Y, Caplan B, Saito H, Furue M, Oettgen HC, Okayama Y, Kawakami T. | Allergol Int. | 2009 |
| Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. |
Xiao W, Hong H, Kawakami Y, Kato Y, Wu D, Yasudo H, Kimura A, Kubagawa H, Bertoli LF, Davis RS, Chau LA, Madrenas J, Hsia CC, Xenocostas A, Kipps TJ, Hennighausen L, Iwama A, Nakauchi H, Kawakami T. | Cancer Cell. | 2009 |
| Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. |
Kawakami Y, Tomimori Y, Yumoto K, Hasegawa S, Ando T, Tagaya Y, Crotty S, Kawakami T. | J Exp Med. | 2009 |
| Pivotal advance: IgE accelerates in vitro development of mast cells and modifies their phenotype. |
Kashiwakura J, Xiao W, Kitaura J, Kawakami Y, Maeda-Yamamoto M, Pfeiffer JR, Wilson BS, Blank U, Kawakami T. | J Leukoc Biol. | 2008 |
| Regulation of myeloproliferation and M2 macrophage programming in mice by Lyn/Hck, SHIP, and Stat5. |
Xiao W, Hong H, Kawakami Y, Lowell CA, Kawakami T. | J Clin Invest. | 2008 |
| Human IgE+ and IgE- are not equivalent to mouse highly cytokinergic IgE. |
Xie L, Schroeder JT, Langdon JM, Sora-Scott RS, Kawakami T, MacDonald SM. |
J Allergy Clin Immunol. |
2008 |
| Basophils now enhance memory. |
Kawakami T. |
Nat Immunol. |
2008 |